Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Type 2 DiabetesChronic Kidney Disease Stage 3
Interventions
DEVICE

CamAPS HX

The CamAPS HX fully closed-loop system consists of an insulin pump, a continuous glucose monitoring (CGM) sensor, as well as the CamAPS HX app, which resides on a smartphone and communicates wirelessly with the insulin pump.

DEVICE

Standard insulin therapy with CGM

Participants will continue their standard insulin therapy with a Freestyle Libre 3 CGM

Trial Locations (2)

1011

NOT_YET_RECRUITING

Centre Hospitalier Universitaire Vaudois, Lausanne

Unknown

RECRUITING

CHUV, Lausanne

All Listed Sponsors
collaborator

Swiss National Science Foundation, Switzerland

UNKNOWN

collaborator

Institute of Primary Health Care (BIHAM), Switzerland

UNKNOWN

lead

Heba Al-Alwan

OTHER